ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

Dec 10 2024 97 ep. 11 mins 279
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research Podcast artwork

The American College of Cardiology offers select interviews and summaries of cardiology’s most interesting research areas from ACCEL’s renowned library, hosted by ACCEL Editor-in-Chief Alison L. Bailey, MD, FACC, FAACPVR.

  Health & Fitness  Education
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Top Takeaways from 2024: Preventive Cardiology with Noel Bairey Merz, MD, FACC

Dec 10 2024 18 mins  
In this interview, Noel Bairey Merz, MD, FACC, and Alison L. Bailey, MD FACC, discuss the Top Preventive Cardiology Takeaways from 2024. Dr. Bairey Merz discusses the SELECT and SUMMIT trials, the impact of cardiac interventions on the carbon footprint, and more. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al; on behalf of the SELECT Trial Investigators. Semaglutide and car

Top Takeaways from 2024: Interventional Cardiology with Deepak L. Bhatt, MD, MPH, MBA, FACC

Dec 03 2024 16 mins  
In this interview, Deepak L Bhatt, MD, MPH, MBA, FACC, and Alison L. Bailey, MD FACC, discuss the Top Interventional Takeaways from 2024. Dr. Bhatt discusses the CLEAR SYNERGY, DanGer Shock, EARLY TAVR trials and more. Jolly SS, d’Entremont MA, Lee SF, et al., for the CLEAR Investigators. Colchicine in Acute Myocardial Infarction. N Engl J Med 2024;Nov 17:[Epub ahead of pr

Top Takeaways from 2024: CV Imaging with Thomas H. Marwick, MD, PhD, FACC

Nov 26 2024 23 mins  
In this interview, Thomas H. Marwick, MD, PhD, FACC, and Alison L. Bailey, MD FACC, discuss the Top Takeaways from 2024 in Cardiovascular (CV) Imaging. Dr. Marwick discusses the SCOT-HEART trial, patient-echo reports augmented by AI, tricuspid valve regurgitation, and more. Dahl JS, Julakanti R, Ali M, Scott CS, Padang R, Pellikka PA. Cardiac damage in early aortic stenos

Key Messages from the ACC Board of Trustees Health Equity Action Plan

Nov 19 2024 11 mins  
Disparities in health care disproportionally impact under-resourced and minority communities resulting in excess mortality and morbidity. Decreasing and eliminating these disparities will improve health statistics for all. The American College of Cardiology's (ACC) Health Equity Task Force is demonstrating its commitment to health equity through championing the improvement of pa

How Has Antithrombotic Therapy for PAD Changed Over the Last Decade?

Nov 12 2024 10 mins  
Medical therapy is critical in preventing the worst complications of peripheral artery disease (PAD), among them heart attack, stroke, bleeding risk, and leg disease, which could lead to acute limb ischemia and amputation. Blood thinning medications (antithrombotic therapy) have shown rapid evolution and broad benefits and novel approved strategies that improve outcomes are availa

What Aspects of Cardiovascular Care are Most Primed for Disruption with AI?

Nov 05 2024 14 mins  
Patients can benefit from better healthcare access and outcomes by services that are enabled by artificial intelligence (AI). The current state of technology is evolving to now allow diagnosis of advanced conditions from simple diagnostic testing, broadening the scope of early diagnosis and treatment. What are the safe cards for the deployment of AI in real-world clinical care

Real-time AI to Influence Clinical Decisions and Practice Towards Evidence-based Care: RAPIDxAI Trial

Oct 29 2024 10 mins  
Can algorithms improve the management of patients with myocardial injury? Is there a tool to aid diagnosing patients faster and more accurately leading to appropriate treatment sooner to optimize results? This study highlights the challenges and opportunities associated with the integration of artificial intelligence (AI) into health care to improve outcomes. In this interv

Effect of Antihypertensive Timing on Mortality and Morbidity: BedMed and BedMed-Frail Trials

Oct 22 2024 12 mins  
The BedMed and BedMed-Frail trials assisted in providing clarity as to the daily timing of prescribed blood pressure medication. The two trials, one conducted in a general primary-care population and the other among nursing-home residents, determined no difference in major cardiovascular events or safety between blood pressure (BP) medication distribution in the evening or morning

Effect of Antihypertensive Timing on Mortality and Morbidity: BedMed and BedMed-Frail Trials

Oct 22 2024 12 mins  
The BedMed and BedMed-Frail trials assisted in providing clarity as to the daily timing of prescribed blood pressure medication. The two trials, one conducted in a general primary-care population and the other among nursing-home residents, determined no difference in major cardiovascular events or safety between blood pressure (BP) medication distribution in the evening or morning

Potassium Supplementation and the Prevention of Afib After Cardiac Surgery: TiGHT-K Trial

Oct 15 2024 9 mins  
The goal of the TIGHT K trial was to evaluate if prescribing relaxed control of potassium levels and only giving supplements in the rare event that levels became pathologically low was equally as effective in preventing atrial fibrillation (AFib) after cardiac surgery as tightly controlling levels. In this interview, Drs. Steven Nissen and Benjamin O’Brien discuss the TI